Business Context and Reporting Period
This Form 8-K Current Report was filed by MacroGenics, Inc. on March 2, 2026. The report discloses a corporate governance event regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or performance data.
Material Changes
The material change reported is the departure of a director:
- Event: Jay Siegel, M.D., informed the Board on February 25, 2026, that he will not stand for re-election as a Class I director at the 2026 Annual Meeting of Stockholders.
- Reason: The departure is for personal reasons.
- Context: The Company stated the decision was not the result of any disagreement with the Company or matters relating to its operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on financial performance, or discussion of risks and contingencies beyond the standard disclosure of the director's departure.
Key Facts for Investors to Verify
- Confirm the composition of the Board of Directors following the 2026 Annual Meeting of Stockholders.
- Verify if a successor director has been nominated to replace Dr. Siegel.
- Review the Company's proxy statement for the 2026 Annual Meeting for further details on director elections.